Abstract: A method of determining an effective method for control of soil pathogens in a soil which includes the step of measuring the pH of the soil, measuring the organic carbon content of the soil, measuring the buffering capacity of the soil, adding a nitrogen containing material and a pH reducing agent to reduce the soil pH below 5.5 when the buffering capacity of the soil is below a predetermined amount, and adding a nitrogen containing material and a pH raising agent to raise the pH above 8.5 when the organic carbon content is less than 1.7% by weight.
Abstract: A strong, thin flexible mineralized collagen membrane is disclosed that is useful for such medical applications as a barrier for guided tissue regeneration, periodontal defect repair, bone grafts and skin wound repair. The mineralized collagen membrane comprises a substantially homogeneous mineralized collagen composite consisting essentially of about 30% to about 70% by weight of a collagen component and about 30% to about 70% by weight of a calcium phosphate minerals component precipitated from a collagen slurry by a soluble calcium ion-containing solution and a soluble phosphate ion-containing solution. The calcium phosphate minerals component has a mole ratio of calcium to phosphate in the range of about 1.0 to about 2.0. The thin mineralized collagen membrane has a bulk density of the membrane of at least about 1.0 g/cm3 and has a thickness not greater than about 0.5 mm and preferably not greater than about 0.3 mm.
Abstract: A method for controlling Tylenchid plant-parasitic nematodes through application of an effective amount of an alkaline-stabilized sludge is described. In accordance with particular embodiments, the alkaline-stabilized sludge may be applied to the plant, seed or locus thereof.
Type:
Grant
Filed:
June 16, 2000
Date of Patent:
June 18, 2002
Assignee:
Her Majesty the Queen in right of Canada, as represented by
c/o Minister of Agriculture and Agri-Food Canada
Abstract: The bacteriophage has a high level of specificity to a certain specific pathogenic bacterium so that the bacteriophage can surely kill the pathogenic bacterium as a host through phogocytic action. The bio-bactericidal material containing the bacteriophage can be applied to food such as fresh food, etc., and to places, etc. or to even persons for cooking food material such as restaurants, school kitchens, etc., or any other thing which requires disinfection from pathogenic bacteria, and it can kill pathogenic bacteria. The bio-bactericidal material containing a cocktail of two or more different kinds of the bacteriophages can kill corresponding kinds of pathogenic bacteria concurrently. Further, the phage can infect only the pathogenic bacterium as a host bacterium, and does not infect persons, making it very safe and useful.
Abstract: A thin, strong, flexible mineralized collagen membrane is disclosed that is useful for such medical applications as a barrier for guided tissue regeneration, periodontal defect repair, bone grafts and skin wound repair. The mineralized collagen membrane comprises a substantially homogeneous mineralized collagen composite consisting essentially of about 30% to about 70% by weight of a collagen component and about 30% to about 70% by weight of a calcium phosphate minerals component precipitated from a collagen slurry by a soluble calcium ion-containing solution and a soluble phosphate ion-containing solution. The calcium phosphate minerals component has a mole ratio of calcium to phosphate in the range of about 1.0 to about 2.0. The thin, strong, flexible mineralized collagen membrane has a bulk density of at least about 1.0 g/cm3.
Abstract: Disclosed are bovine excretion extracts having anticancer and anti-inflammatory activity prepared by a process comprising the step of extracting bovine excretion with a polar solvent selected from the group consisting of lower alcohol, lower ketone, acetonitrile, water and mixtures thereof, a process for preparing the same, and the use thereof as an anticancer agent or adjuvant, or an anti-inflammatory agent.
Type:
Grant
Filed:
July 7, 1999
Date of Patent:
June 19, 2001
Inventors:
Bok Deuk Kim, Man Ki Park, Jeong Hill Park, Seung Ki Lee, Jin Ho Chung, Sung Won Park
Abstract: The present invention relates to animal scent attractants. More particularly, the present invention relates to a composition of matter for amplifying and preserving animal scents. Fox urine, coyote urine, deer urine, elk urine, moose urine, bear urine, rabbit urine, fish oils, and sheep manure are examples of substances which can be used with the present invention.
Abstract: A nutraceutical composition comprising water insoluble antler powder or water soluble antler powder or a combination of both. Also disclosed is a method of producing antler powder, either water soluble, water insoluble or a combination of both.
Abstract: The invention concerns a procedure for testing a potentially-active substance used in the hair-care field, this procedure being characterized by the fact that a fragment of at least one hair follicle without dermal papilla is isolated, this fragment being taken from beneath the point of attachment of the sebaceous gland and excluding the portion of the hair shaft located above the point of attachment of the sebaceous gland; that this fragment is incubated in a suitable culture medium for a sufficient period; that this fragment is placed in contact with a potentially-active hair-care substance; that a marker of the activity of said tested substance is quantitatively determined; and that the results of this determination are assessed as they compare to a control.
Type:
Grant
Filed:
February 18, 1997
Date of Patent:
April 6, 1999
Assignee:
Societe L'Oreal S.A.
Inventors:
Fran.cedilla.oise Jarrousse, Stephane Commo, Olivier Gaillard, Bruno Bernard
Abstract: There is provided a skin substitute that can suitably be used for covering the surface of a damaged skin area which is typically a wound produced by a traumatic local loss of the skin of the human body as a result of a burn or some other cause of damage. It is a skin substitute of a laminate comprising a squid chitin sheet and a fish skin collagen coat layer, which may be a salmon skin collagen coat layer. Such a skin substitute effectively exploits the suppleness and the effect of proving an environment for encouraging the production of lysozyme and defending the wound of squid chitin and, at the same time, compensate the disadvantage of poor adhesion of fibroblast cells that operate for curing the wound.
Abstract: A non-toxic rodent deterrent made from dried fecal matter and/or dried urine from mammals of the Mustelidae Family (e.g. weasels, ferrets, minks, martens, etc.). The rodent deterrent material may be used in its bulk from or this material may be placed in a container for either interior or exterior use.
Abstract: The invention relates to cosmetic or pharmaceutical, particularly dermatological, compositions. More particularly, the invention relates to the utilization of an extract of coleus Esquirolii, coleus Scutellariodes or Coleus Xanthanthus or one of the mixtures thereof for the preparation of cosmetic or pharmaceutical, particularly dermatological, composition. In particular, the invention helps to efficiently promote skin or hair pigmentation.
Type:
Grant
Filed:
February 21, 1996
Date of Patent:
July 15, 1997
Assignee:
L.V.M.H. Recherche
Inventors:
Alain Meybeck, Frederic Bonte, Marc Dumas
Abstract: Humate, a composition of primarily humic acids, carbon, and organic matter, is used as a human dietary supplement. The humate may be mixed with food, liquid drinks, or flavoring and ingested. The powder, granule, or water-soluble powder form of humate may also be mixed with other known dietary supplements such as multi-vitamins and be formed into capsules and tablets. The preferred humate is mined from the Menefee Geological Formation in Northwestern New Mexico.
Abstract: A method of treating chronic disorders associated with the presence of abnormal microflora or an abnormal distribution of microflora in the gastrointestinal tract. The method involves the removal of at least a portion of the host's existing enteric microflora and the substitution of an effective amount of predetermined microflora. Pharmaceutical compositions which comprise viable microorganisms in a composition resembling the host's normal healthy faecal flora are also disclosed.
Abstract: A purified naturally occurring natriuretic compound, identified as Natriuretic Hormone, and a method for isolation of the compound. The natriuretic compound has a molecular weight of about 360, a molecular formula of C.sub.21 H.sub.28 O.sub.5 and with a steroidal nucleus. The compound is useful as a diuretic in the treatment of diseases such as heart disease and hypertension.
Abstract: A novel wound dressing material is produced by a chemical treatment of animal fibers, particularly, wool, to strip off the keratin layers of the surfaces of the fibers so as to expose the non-keratin protein in the underlayers, which is hydrophilic. The wound dressing material provides healing and regenerating effects on the wounds, and can be produced at a low cost.
Abstract: Rationally designed wound cleanser that is physiologically compatible. The wound cleanser comprises a surfactant, an osmotic adjuster, a buffering agent, and water. The composition may also contain a preservative, a sudsing agent, a skin protectant, a pH adjuster, and a stabilizer.
Abstract: A purified naturally occurring natriuretic compound, identified as Natriuretic Hormone, and a method for isolation of the compound. The natriuretic compound has a molecular weight of about 360, a molecular formula of C.sub.21 H.sub.28 O.sub.5 and with a steroidal nucleus. The compound is useful as a diuretic in the treatment of diseases such as heart disease and hypertension.
Abstract: This invention relates to activated protein-containing compositions comprising reducing agents, oxidizing agents and/or anti-oxidants and methods of use. The therapeutic compositions and methods of the present invention are particularly effective in promoting wound healing, and in inhibiting certain skin disorders, including eczema and seborrhea, sclerodema and acne. The therapeutic compositions and methods of the present invention have also shown enhanced effect as veterinary tools in reducing the debilitation associated with certain skin conditions in mammals including eczematoid dermatitis, chronic dermatitis, equine exuberant granuloma ("proud flesh"), decubitis ulcers, and canine cutaneous granulomas ("lick" granuloma).
Abstract: This invention discloses a fibrinophilic urokinase complex which is a complex of urokinase with a urokinase inhibitor or tissue activator inhibitor and has a molecular weight of 97,500.+-.3,000 and a method for the production of this fibrinophilic urokinase complex from urine. The urokinase complex can be used, as a thombolytic agent exhibiting an outstanding ability to dissolve thrombus.
Abstract: A multiphasic sustained release injectable delivery system is provided, as well as a method for treating humans and other mammals with that multiphasic sustained release system.
Abstract: A pharmaceutical composition for the treatment and prevention of erythma and acne comprises in a pharmaceutically acceptable carrier from about 1 to 10 weight percent based on the total weight of the composition of a delipidized and purified keratin polymer obtained from animal starting material containing keratin, the keratin polymer being in the free state.